HIPRA

Serial Number 97243682
Registration 8061096
700

Registration Progress

Application Filed
Jan 28, 2022
Under Examination
Dec 19, 2023
Approved for Publication
Oct 24, 2023
Published for Opposition
Oct 24, 2023
Registered
Dec 9, 2025

Trademark Image

HIPRA

Basic Information

Serial Number
97243682
Registration Number
8061096
Filing Date
January 28, 2022
Registration Date
December 9, 2025
Published for Opposition
October 24, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 9, 2025
Registration
Registered
Classes
005 042

Rights Holder

LABORATORIOS HIPRA, S.A.

99
Address
Avinguda de La Selva nº 135
AMER (GIRONA) 17170
ES

Ownership History

LABORATORIOS HIPRA, S.A.

Original Applicant
99
AMER (GIRONA) ES

LABORATORIOS HIPRA, S.A.

Owner at Publication
99
AMER (GIRONA) ES

LABORATORIOS HIPRA, S.A.

Original Registrant
99
AMER (GIRONA) ES

Legal Representation

Attorney
LEIGH ANN LINDQUIST

USPTO Deadlines

All Deadlines Cleared

All 4 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

42 events
Date Code Type Description Documents
Dec 9, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Dec 9, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 19, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Nov 19, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Oct 3, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jun 18, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 18, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 19, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Dec 19, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 19, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 20, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 20, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 20, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 20, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 19, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 24, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 24, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 4, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 18, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 18, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Sep 18, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Sep 18, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Sep 18, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Sep 6, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 6, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 6, 2023 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Jun 12, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jun 12, 2023 GNFR O FINAL REFUSAL E-MAILED Loading...
Jun 12, 2023 CNFR R FINAL REFUSAL WRITTEN Loading...
May 24, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 23, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 23, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 23, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 23, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 23, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 9, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 24, 2022 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
Feb 24, 2022 ALIE A ASSIGNED TO LIE Loading...
Feb 18, 2022 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Feb 1, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 1, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical products, namely, biological vaccines for human and veterinary use; biological preparations for medical and veterinary use, namely, veterinary vaccines; veterinary preparations for the treatment of intestinal bacteria; anti- infective products for veterinary use; insecticidal washing products for veterinary use; veterinary products and substances, namely, vaccines for prevention of animal illness; biological reagents for veterinary use; diagnostic reagents for veterinary use; reagents for clinical analyses for veterinary purposes; reagents for microbiological analyses for veterinary purposes; reagents for chemical analyses for veterinary purposes; reagents for veterinary diagnosis; reagents for diagnostic tests for veterinary purposes; reagents for use with analyzers for veterinary purposes; reagents for use in analyses for veterinary use, reagents for in-vitro laboratory use for veterinary purposes; reagents for use in analysis for veterinary use, reagents for in-vitro laboratory use for veterinary purposes; chemical reagents for medical or veterinary purposes; chemical reagents for veterinary use; reagents and media for medical and veterinary diagnostic purposes; nucleic acid sequences for medical and veterinary use; dietary supplements for veterinary use; veterinary substances and preparations, namely, vaccines for prevention of animal illness; oral vaccine preparations; vaccine preparations for human use; vaccines; influenza vaccines; vaccines against pneumococcal infections; vaccines for horses; vaccines for cattle; vaccines for infections in animal hooves; vaccines for human use; veterinary vaccines; viral vaccines
First Use Anywhere: 20210000
First Use in Commerce: Jul 23, 2024
Class 042
Scientific and technological services, as well as associated research and design services, namely, scientific research, analysis and testing in the field of pharmaceutical, veterinary, and sanitary products and material, surgical, medical, and veterinary apparatus, devices, and instruments; industrial analysis and research services in the field of pharmaceutical, veterinary, and sanitary products and material, surgical, medical, and veterinary apparatus, devices, and instruments, as well as of computer software related to the biomedical and pharmaceutical sector, and industrial design services; quality control services for others in the field of pharmaceutical, veterinary, and sanitary products and material, surgical, medical, and veterinary apparatus, devices and instruments; design and development of computer hardware and software; research and development of vaccines; veterinary laboratory services; services for assessing the effectiveness of veterinary medicines; design of laboratory animal housing systems; biotechnology research for determining the neuronal survival of molecules in animal models; research regarding farm animal breeding; genetic tests of laboratory animals for research; consultancy in pharmaceutical research; consultancy related to pharmacology; consultancy related to pharmacogenetics research; consultancy related to pharmaceutical research and development; development of pharmaceutical preparations and medicines; development of pharmaceutical products; clinical studies for pharmaceutical products; evaluation of pharmaceutical products; scientific and medical research information regarding pharmaceutical products and clinical trials; inspection of pharmaceutical products; scientific research in the field of pharmaceuticals; research in the field of pharmacogenetics; research regarding pharmaceutical products; research and development in the field of pharmaceuticals and biotechnology; pharmaceutical research and development; research and development for the pharmaceutical industry; conducting clinical trials for pharmaceutical products; conducting early evaluations in relation to new pharmaceutical products; pharmaceutical drug development services; drug discovery services; pharmaceutical product efficacy assessment services; medical and pharmacological research services; pharmaceutical research and development services; information technology services for the pharmaceutical and health-care industries, namely, information technology consulting services; provision of information regarding results of clinical trials relating to pharmaceutical products; electronic storage of medical records; design and development of medical diagnostic apparatus; scientific research for medical purposes; medical laboratories; programming for computers in the medical field; information and data services regarding medical and veterinary research and development; services of a medical laboratory; non-medical ultrasound imaging services; provision of scientific information regarding medical disorders and their treatment; research and development of vaccines and medicines; biological research and analysis; development of computer software in the pharmaceutical, medical, veterinary, sanitary and diagnostic field; clinical research in the field of veterinary preparations, biotherapeutic medicines, and antibodies; blood testing services for scientific research; scientific analysis services relating to the assessment of bacteria content in liquids
First Use Anywhere: 20210000
First Use in Commerce: Jul 23, 2024

Additional Information

Design Mark
The mark consists of the stylized wording "HIPRA" in white inside a blue rectangle.
Color Claim
The color(s) white and blue is/are claimed as a feature of the mark.

Classification

International Classes
005 042